EGFR and small cell lung carcinoma: Our GSEA also showed that cancer-related pathways were significantly enriched in the high-risk group, including those related to pancreatic cancer, small-cell lung cancer, EC, cancer, ErbB signaling, MAPK, and other common cancers [42, 43].